Properties (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:brand |
Strong brand.
|
| gptkbp:communityFeedback |
Positive feedback.
|
| gptkbp:hasAbstract |
This patent describes a method for treating a specific disease using a novel compound.
|
| gptkbp:hasApplicationNumber |
10/123,456.
|
| gptkbp:hasAssignee |
Company XYZ
|
| gptkbp:hasClaim |
20
|
| gptkbp:hasCollaborationsWith |
Collaboration with University.
|
| gptkbp:hasCompetitors |
Unique formulation.
|
| gptkbp:hasContribution |
High sales.
Rapid growth. Pharmacies. |
| gptkbp:hasCountry |
gptkb:United_States
|
| gptkbp:hasDescription |
A detailed description of the method and its applications.
|
| gptkbp:hasFeature |
Positive outlook.
Significant improvement. |
| gptkbp:hasFieldOfUse |
pharmaceuticals
|
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFunding |
Funded_by_NIH.
|
| gptkbp:hasGoals |
International markets.
|
| gptkbp:hasImpactOn |
High impact.
|
| gptkbp:hasInternationalClassification |
A61K
|
| gptkbp:hasInventor |
gptkb:John_Doe
Jane_Smith |
| gptkbp:hasLegalEvent |
Maintenance fee paid.
|
| gptkbp:hasLegalStatus |
Active
Licensed_to_Company_ABC. |
| gptkbp:hasLocalCuisine |
Phase III.
|
| gptkbp:hasOccupation |
Compliant.
FDA_approved. |
| gptkbp:hasPartnershipsWith |
Strategic partnerships.
Marketed. High commercial value. |
| gptkbp:hasPriorityDate |
2004-09-14
2003-02-06 2024-09-14 |
| gptkbp:hasPrograms |
High awareness.
Well-tolerated. |
| gptkbp:hasPublications |
2004-0123456 A1
|
| gptkbp:hasRelatedPatent |
Incremental innovation.
Utility patent. US_6,789,098_B12 |
| gptkbp:hasResearchInterest |
medical research.
Conducted. therapeutics. Significant contributions. Positive clinical trials. |
| gptkbp:hasSpecialty |
Protected.
|
| gptkbp:hasTechnicalField |
biotechnology.
|
| gptkbp:hasTechnology |
Improved treatment efficacy.
Transferred to Company XYZ. TRL_9. |
| gptkbp:hasTheme |
20 years.
|
| gptkbp:hasTitle |
Method for treating a disease
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,097 B12
|
| gptkbp:inventiveStep |
Novel compound.
|
| gptkbp:isAssignedTo |
XYZ_Pharmaceuticals.
|
| gptkbp:isCitedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:isCitedIn |
Research papers.
|
| gptkbp:isFiledIn |
gptkb:United_States
|
| gptkbp:isFiledUnder |
35 U.S.C. § 111.
|
| gptkbp:isPartOf |
Patent_family_US_6,789,097.
|
| gptkbp:isPublishedIn |
USPTO_database.
|
| gptkbp:isReferencedBy |
US_8,765,432_B1.
|
| gptkbp:isRelatedTo |
gptkb:US_6,123,456_B1
|
| gptkbp:market |
Direct sales.
Competition. Growing market. Approved for use. Pharmaceutical products. |